United States · Platforms & data · The Motley Fool

Bristol Myers Squibb's Growth Portfolio Now Brings In $7.7 Billion a Quarter. Here's Why That Changes the Stock's Story.

Published by The Motley Fool · United States 1 h ago

Bristol Myers Squibb's Growth Portfolio Now Brings In $7.7 Billion a Quarter. Here's Why That Changes the Stock's Story. — Bristol Myers Squibb's Growth Portfolio Now Brings In $7.7 Billion a Quarter. Here's Why That Changes the Stock's Story. · The Motley Fool

Detailed summary

Bristol Myers Squibb is facing down the expiration of patent protections for older drugs, but new drugs are starting to show promise.

Read the full article on The Motley Fool Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.fool.com)

Also worth reading

Washington can start delivering on affordability by rejecting Trump’s tariffs

Adobe's new agentic tools appear impressive, but BTIG seeks more evidence of growth

Brookfield, CPPIB consortium enters next round in Uniper sales process, sources say

Eric Trump-backed robot soldier startup can't pay staff after founder borrowed $4.6 million from company to buy home

Bernicke Wealth Management Ltd. Makes New Investment in Intel Corporation $INTC

Apple users are about to lose something they’ve had for 28 years